School of Medicine Clinical Research Office Recognized for Work in Vaccine Trial

Congratulations to the School of Medicine Clinical Research Office for being recognized among the top enrollers in the United States for its GlazoSmithKline (GSK) Group B Meningococcus vaccine trial. So far, 57 participants have enrolled in the trial.

The trial looks at children’s immune response when the study drug Bexsero, and a second vaccine, Prevnar 13, are given with other routine childhood vaccines to 6-week to 24-month-old children.

Meera Varnam, MD, professor of pediatrics, serves as principle investigator, with Patty Sully serving as lead coordinator. As a result of being a top enroller, Sully was invited to present at an Interim Investigator meeting, where GSK Medical Director Andrew Trofa, MD, shared the following note after her presentation: “I wanted to thank you for sharing your experience with us yesterday. Simply superb. Your experience and confidence were obvious. It’s very reassuring to have you on this, and I hope, many future studies.”

Kudos to Sully, Varnam and other coordinators from the Clinical Research Office who helped on the project including Kim Peterson, Elsie Moran and Amanda Zamora.